UNSPSC 51421802: Budesonide

This classification denotes a therapeutic glucocorticoid, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier Q3OKS62Q6X. European Medicines Agency schedules Budesonide in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB05955MIG. Budesonide generally arises in the molecular formula C25H34O6.

UNSPSC 51421802 Budesonide is a Commodity code that designates a specific pharmaceutical product—a corticosteroid inhaler used to manage respiratory conditions—yet the most recent state and local opportunities posted under this code show a marked mismatch: Seminole County, Florida's IFB solicitation for Naloxone and Safe Drug Deactivation Systems bears no pharmaceutical relationship to budesonide and appears to represent a data-classification error. State and local procurement systems occasionally tag opportunities with codes that do not reflect the goods or services being acquired; this code shows little relevant recent activity aligned with its nominal scope.

The single recent opportunity on record is Seminole County, Florida's IFB 60459723LAS (posted June 30, 2026, response due July 26, 2023) for 1,900 units of Naloxone and 800 Safe Drug Deactivation Systems annually with quarterly deliveries to the Seminole County Community Health Building in Sanford, Florida. That solicitation requests pricing on a fixed-fee basis with an initial two-year term and one-year renewal option, and requires E-Verify compliance, drug-free workplace certification, and standard commercial and professional liability insurance. The county specifies no set-aside designations for disadvantaged enterprises. Without additional recent opportunities under this code that actually concern budesonide procurement, geographic concentration and issuing-body patterns cannot be characterized.